Kendall Capital Management Merck & Co., Inc. Transaction History

Kendall Capital Management

$293 Million
Q2 2024

A detailed history of Kendall Capital Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Kendall Capital Management holds 18,955 shares of MRK stock, worth $2.15 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares

18,955

Previous 17,900 5.89%

Holding current value

$2.15 Million

Previous $2.36 Million 0.64%

% of portfolio

0.8%

Previous 0.84%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$123.8 - $132.96 $130,609 - $140,272	1,055 Added 5.89%	18,955 $2.35 Million
Q1 2024 May 10, 2024	SELL	$113.24 - $131.95 $82,099 - $95,663	-725 Reduced 3.89%	17,900 $2.36 Million
Q4 2023 Jan 26, 2024	SELL	$100.18 - $109.02 $40,572 - $44,153	-405 Reduced 2.13%	18,625 $2.03 Million
Q3 2023 Oct 31, 2023	SELL	$102.95 - $114.33 $11,839 - $13,147	-115 Reduced 0.6%	19,030 $1.96 Million
Q2 2023 Jul 28, 2023	BUY	$108.61 - $118.38 $49,960 - $54,454	460 Added 2.46%	19,145 $2.21 Million
Q1 2023 May 11, 2023	SELL	$102.94 - $114.86 $13,691 - $15,276	-133 Reduced 0.71%	18,685 $1.99 Million
Q4 2022 Jan 30, 2023	SELL	$87.44 - $112.11 $61,820 - $79,261	-707 Reduced 3.62%	18,818 $2.09 Million
Q3 2022 Nov 02, 2022	BUY	$84.53 - $94.96 $43,702 - $49,094	517 Added 2.72%	19,525 $1.68 Million
Q2 2022 Jul 29, 2022	BUY	$83.49 - $94.64 $31,308 - $35,490	375 Added 2.01%	19,008 $1.73 Million
Q1 2022 May 06, 2022	BUY	$73.51 - $82.4 $73,142 - $81,988	995 Added 5.64%	18,633 $1.53 Million
Q4 2021 Jan 28, 2022	BUY	$72.28 - $90.54 $101,192 - $126,756	1,400 Added 8.62%	17,638 $1.35 Million
Q3 2021 Nov 05, 2021	BUY	$71.68 - $78.83 $78,848 - $86,713	1,100 Added 7.27%	16,238 $1.22 Million
Q2 2021 Jul 30, 2021	BUY	$70.31 - $77.77 $224,640 - $248,475	3,195 Added 26.75%	15,138 $1.18 Million
Q1 2021 May 05, 2021	BUY	$68.86 - $81.11 $112,930 - $133,020	1,640 Added 15.92%	11,943 $921,000
Q4 2020 Feb 08, 2021	BUY	$71.77 - $79.65 $114,832 - $127,440	1,600 Added 18.38%	10,303 $843,000
Q3 2020 Oct 22, 2020	BUY	$73.18 - $82.95 $174,534 - $197,835	2,385 Added 37.75%	8,703 $722,000
Q2 2020 Jul 30, 2020	BUY	$70.42 - $80.13 $111,967 - $127,406	1,590 Added 33.63%	6,318 $489,000
Q1 2020 Apr 27, 2020	BUY	$63.36 - $87.82 $41,564 - $57,609	656 Added 16.11%	4,728 $364,000
Q4 2019 Jan 24, 2020	BUY	$77.58 - $87.54 $36,074 - $40,706	465 Added 12.89%	4,072 $370,000
Q3 2019 Nov 12, 2019	BUY	$76.08 - $82.93 $69,613 - $75,880	915 Added 33.99%	3,607 $304,000
Q1 2019 May 08, 2019	SELL	$69.58 - $79.36 $27,484 - $31,347	-395 Reduced 12.8%	2,692 $224,000
Q3 2018 Oct 29, 2018	BUY	$57.69 - $67.84 $178,089 - $209,422	3,087 New	3,087 $219,000

Others Institutions Holding MRK

# of Institutions

3,830

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $288B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kendall Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Kendall Capital Management with notifications on news.

Account

Kendall Capital Management Merck & Co., Inc. Transaction History